130 related articles for article (PubMed ID: 28456375)
1. Rolipram improves facilitation of contextual fear extinction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Kinoshita KI; Muroi Y; Unno T; Ishii T
J Pharmacol Sci; 2017 May; 134(1):55-58. PubMed ID: 28456375
[TBL] [Abstract][Full Text] [Related]
2. Serotonin 5-HT
Ishii T; Kinoshita KI; Muroi Y
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717815
[TBL] [Abstract][Full Text] [Related]
3. Gynostemma pentaphyllum Ethanolic Extract Protects Against Memory Deficits in an MPTP-Lesioned Mouse Model of Parkinson's Disease Treated with L-DOPA.
Kim KS; Zhao TT; Shin KS; Park HJ; Cho YJ; Lee KE; Kim SH; Lee MK
J Med Food; 2017 Jan; 20(1):11-18. PubMed ID: 28005447
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV.
Yang L; Calingasan NY; Lorenzo BJ; Beal MF
Exp Neurol; 2008 May; 211(1):311-4. PubMed ID: 18328479
[TBL] [Abstract][Full Text] [Related]
5. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
[TBL] [Abstract][Full Text] [Related]
6. Subchronic rolipram delivery activates hippocampal CREB and arc, enhances retention and slows down extinction of conditioned fear.
Monti B; Berteotti C; Contestabile A
Neuropsychopharmacology; 2006 Feb; 31(2):278-86. PubMed ID: 15988467
[TBL] [Abstract][Full Text] [Related]
7. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions.
Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS
J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system.
Jabaris SS; Sumathy H; Girish R; Narayanan S; Sugumar M; Saravana Babu C; Thanikachalam S; Thanikachalam M
Brain Res; 2015 Oct; 1622():279-91. PubMed ID: 26168894
[TBL] [Abstract][Full Text] [Related]
9. Fear renewal activates cyclic adenosine monophosphate signaling in the dentate gyrus.
Shi YW; Fan BF; Xue L; Wang XG; Ou XL
Brain Behav; 2019 Aug; 9(8):e01280. PubMed ID: 31313894
[TBL] [Abstract][Full Text] [Related]
10. Selective loss of dopaminergic neurons in the substantia nigra pars compacta after systemic administration of MPTP facilitates extinction learning.
Kinoshita K; Tada Y; Muroi Y; Unno T; Ishii T
Life Sci; 2015 Sep; 137():28-36. PubMed ID: 26209139
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats.
Cheng YF; Wang C; Lin HB; Li YF; Huang Y; Xu JP; Zhang HT
Psychopharmacology (Berl); 2010 Oct; 212(2):181-91. PubMed ID: 20640406
[TBL] [Abstract][Full Text] [Related]
12. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
[TBL] [Abstract][Full Text] [Related]
13. Nicotine improved the olfactory impairment in MPTP-induced mouse model of Parkinson's disease.
Yang J; Lv DJ; Li LX; Wang YL; Qi D; Chen J; Mao CJ; Wang F; Liu Y; Hu LF; Liu CF
Neurotoxicology; 2019 Jul; 73():175-182. PubMed ID: 30978411
[TBL] [Abstract][Full Text] [Related]
14. MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway.
Zhu G; Li J; He L; Wang X; Hong X
Br J Pharmacol; 2015 May; 172(9):2354-68. PubMed ID: 25560396
[TBL] [Abstract][Full Text] [Related]
15. Lack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of Parkinson's disease.
Fifel K; Dkhissi-Benyahya O; Cooper HM
Chronobiol Int; 2013 Jul; 30(6):741-55. PubMed ID: 23758587
[TBL] [Abstract][Full Text] [Related]
16. Tangeretin inhibits neurodegeneration and attenuates inflammatory responses and behavioural deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease dementia in rats.
Yang JS; Wu XH; Yu HG; Teng LS
Inflammopharmacology; 2017 Aug; 25(4):471-484. PubMed ID: 28577132
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase inhibition rescues chronic cognitive deficits induced by traumatic brain injury.
Titus DJ; Sakurai A; Kang Y; Furones C; Jergova S; Santos R; Sick TJ; Atkins CM
J Neurosci; 2013 Mar; 33(12):5216-26. PubMed ID: 23516287
[TBL] [Abstract][Full Text] [Related]
18. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats.
Nagakura A; Niimura M; Takeo S
Br J Pharmacol; 2002 Apr; 135(7):1783-93. PubMed ID: 11934820
[TBL] [Abstract][Full Text] [Related]
19. Activation of Hippocampal CREB by Rolipram Partially Recovers Balance Between TNF-α and IL-10 Levels and Improves Cognitive Deficits in Diabetic Rats.
Miao Y; He T; Zhu Y; Li W; Wang B; Zhong Y
Cell Mol Neurobiol; 2015 Nov; 35(8):1157-64. PubMed ID: 26001770
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rb1 prevents MPTP-induced changes in hippocampal memory via regulation of the α-synuclein/PSD-95 pathway.
Qu S; Meng X; Liu Y; Zhang X; Zhang Y
Aging (Albany NY); 2019 Apr; 11(7):1934-1964. PubMed ID: 30958793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
